Long-Term Assets: The sum of all assets classified as non-current.
Vir Biotechnology, Inc. (VIR) had Long-Term Assets of $580.87M for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
$56.38M |
|
$-65.28M |
|
$0.06M |
|
$56.32M |
|
$136.46M |
|
$-80.08M |
|
$15.08M |
|
$-65.00M |
|
$-65.00M |
|
$-65.28M |
|
$-65.28M |
|
$-65.28M |
|
$-65.28M |
|
$-80.08M |
|
-- |
|
135.28M |
|
135.28M |
|
$-0.48 |
|
$-0.48 |
|
| Balance Sheet Financials | |
$1.21B |
|
$92.48M |
|
|
Long-Term Assets |
$580.87M |
$1.79B |
|
$94.07M |
|
-- |
|
$152.54M |
|
$246.61M |
|
$1.55B |
|
$1.51B |
|
$1.55B |
|
135.84M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|